Barbara Styrt

1.6k total citations
39 papers, 1.2k citations indexed

About

Barbara Styrt is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Barbara Styrt has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 12 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Barbara Styrt's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (14 papers), Venomous Animal Envenomation and Studies (6 papers) and Immune Response and Inflammation (6 papers). Barbara Styrt is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (14 papers), Venomous Animal Envenomation and Studies (6 papers) and Immune Response and Inflammation (6 papers). Barbara Styrt collaborates with scholars based in United States, Thailand and Canada. Barbara Styrt's co-authors include Mark S. Klempner, B. Sugarman, MS Klempner, Sherwood L. Gorbach, Robert F. Todd, M. Amin Arnaout, N Dana, J D Griffin, Ross E. Rocklin and G K Chikami and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Barbara Styrt

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Styrt United States 17 368 263 234 226 143 39 1.2k
T. Söderstrom Sweden 22 578 1.6× 319 1.2× 146 0.6× 397 1.8× 96 0.7× 74 1.7k
R. van Furth Netherlands 21 476 1.3× 227 0.9× 308 1.3× 356 1.6× 57 0.4× 42 1.4k
Philip J. Spagnuolo United States 22 334 0.9× 205 0.8× 310 1.3× 389 1.7× 54 0.4× 51 1.5k
P. C. J. Leijh Netherlands 26 832 2.3× 526 2.0× 323 1.4× 320 1.4× 76 0.5× 59 1.9k
Michael P. Everson United States 17 766 2.1× 239 0.9× 148 0.6× 286 1.3× 54 0.4× 32 1.5k
Alma Fulurija Australia 19 373 1.0× 237 0.9× 325 1.4× 308 1.4× 113 0.8× 38 1.2k
Richard V. McCloskey United States 19 473 1.3× 260 1.0× 168 0.7× 488 2.2× 81 0.6× 31 1.6k
Séverine Navarro Australia 28 567 1.5× 587 2.2× 240 1.0× 172 0.8× 126 0.9× 59 2.1k
G. L. Mandell United States 17 360 1.0× 237 0.9× 108 0.5× 120 0.5× 64 0.4× 31 910
C. C. Clawson United States 28 450 1.2× 416 1.6× 261 1.1× 362 1.6× 95 0.7× 56 2.2k

Countries citing papers authored by Barbara Styrt

Since Specialization
Citations

This map shows the geographic impact of Barbara Styrt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Styrt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Styrt more than expected).

Fields of papers citing papers by Barbara Styrt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Styrt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Styrt. The network helps show where Barbara Styrt may publish in the future.

Co-authorship network of co-authors of Barbara Styrt

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Styrt. A scholar is included among the top collaborators of Barbara Styrt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Styrt. Barbara Styrt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Rosemary, Barbara Styrt, & Susan McCune. (2007). FDA perspective on antivirals against biothreats: Communicate early and often. Antiviral Research. 78(1). 60–63. 8 indexed citations
2.
Levy, Mitchell M., Gordon R. Bernard, Rob Fowler, et al.. (2005). Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome. American Journal of Respiratory and Critical Care Medicine. 171(5). 518–526. 42 indexed citations
3.
Styrt, Barbara, Richard E. Chaisson, & Richard D. Moore. (1997). Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients. AIDS. 11(10). 1243–1248. 6 indexed citations
4.
Styrt, Barbara, et al.. (1996). Clinical toxicity of antiretroviral nucleoside analogs. Antiviral Research. 31(3). 121–135. 48 indexed citations
5.
Styrt, Barbara & B. Sugarman. (1991). Estrogens and Infection. Clinical Infectious Diseases. 13(6). 1139–1150. 92 indexed citations
6.
Styrt, Barbara, et al.. (1991). Chemorepulsion of Trichomonads by Products of Neutrophil Oxidative Metabolism. The Journal of Infectious Diseases. 163(1). 176–179. 7 indexed citations
7.
Styrt, Barbara, et al.. (1990). Degranulation of human neutrophils after exposure to bacterial phospholipase C. European Journal of Clinical Microbiology & Infectious Diseases. 9(11). 830–832. 12 indexed citations
8.
Styrt, Barbara, et al.. (1990). Time and temperature dependence of granulocyte damage by leucotoxic supernatants from Pasteurella haemolytica A1. Journal of General Microbiology. 136(11). 2173–2178. 3 indexed citations
9.
Styrt, Barbara. (1990). Infection associated with asplenia: risks, mechanisms, and prevention.. PubMed. 88(5N). 33N–42N. 106 indexed citations
10.
Styrt, Barbara & B. Sugarman. (1990). Antipyresis and fever.. PubMed. 150(8). 1589–97. 60 indexed citations
11.
Styrt, Barbara & Sherwood L. Gorbach. (1989). Recent Developments in the Understanding of the Pathogenesis and Treatment of Anaerobic Infections. New England Journal of Medicine. 321(5). 298–302. 16 indexed citations
12.
Styrt, Barbara, Ross E. Rocklin, & Mark S. Klempner. (1988). Characterization of the neutrophil respiratory burst in atopy. Journal of Allergy and Clinical Immunology. 81(1). 20–26. 38 indexed citations
13.
Styrt, Barbara, Martin A. Schwartz, & Mark S. Klempner. (1988). Calcium release associated with discharge of specific granule contents from human neutrophils. Biochemical and Biophysical Research Communications. 154(3). 1308–1313. 6 indexed citations
14.
Styrt, Barbara & Mark S. Klempner. (1988). Lysosomotropic amines modulate neutrophil calcium homeostasis. Journal of Cellular Physiology. 135(2). 309–316. 18 indexed citations
15.
Styrt, Barbara, Mark S. Klempner, & Ross E. Rocklin. (1988). Comparison of prostaglandins E2 and D2 as inhibitors of respiratory burst in neutrophils from atopic and nonatopic subjects. Inflammation. 12(3). 213–221. 2 indexed citations
16.
Styrt, Barbara & Mark S. Klempner. (1988). Effects of pH on killing of Staphylococcus aureus and Escherichia coli by constituents of the neutrophil phagolysosome. Journal of Medical Microbiology. 25(2). 101–107. 11 indexed citations
17.
Styrt, Barbara, Martin A. Schwartz, & Mark S. Klempner. (1987). Linkage between neutrophil degranulation and calcium discharge. Biochemical and Biophysical Research Communications. 146(3). 1386–1391. 4 indexed citations
18.
Styrt, Barbara & Mark S. Klempner. (1985). Modification of interactions between neutrophils and staphylococci by lysosomotropic weak bases. Infection and Immunity. 50(2). 415–419. 11 indexed citations
19.
Klempner, Mark S. & Barbara Styrt. (1983). Alkalinization of the intralysosomal pH by clindamycin and its effects on neutrophil function. Journal of Antimicrobial Chemotherapy. 12(suppl C). 39–50. 15 indexed citations
20.
Klempner, Mark S. & Barbara Styrt. (1983). Alkalinizing the intralysosomal pH inhibits degranulation of human neutrophils.. Journal of Clinical Investigation. 72(5). 1793–1800. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026